New study aims to unlock why immunotherapy fails in most head and neck cancer patients
NCT ID NCT07211139
First seen Oct 31, 2025 · Last updated Jun 15, 2026 · Updated 31 times
Summary
This study looks at 30 adults with advanced head and neck cancer who are receiving standard immunotherapy plus chemotherapy. The goal is to find biological markers in tumors and blood that can predict who will benefit from treatment. By understanding these changes, doctors hope to personalize therapy and improve outcomes in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Samsung Medical Center
RECRUITINGSeoul, Seoul, 06351, South Korea
Conditions
Explore the condition pages connected to this study.